Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2018 $ 5,725 $ 148,888,635 $ (121,370,240) $ 27,524,120
Beginning balance, shares at Dec. 31, 2018 57,247,496      
Stock-based compensation expense 11,981,655 11,981,655
Issuance of common stock, net of issuance costs of $6,039,423 $ 620 37,718,078 37,718,698
Issuance of common stock, net of issuance costs, shares 6,198,500      
Issuance of common stock upon exercise of stock options $ 10 386,800 $ 386,810
Issuance of common stock upon exercise of stock options, shares 107,029     107,029
Issuance of common stock upon exercise of warrants $ 112 (112)
Issuance of common stock upon exercise of warrants, shares 1,119,868      
Net Loss     (71,453,718) (71,453,718)
Ending balance, value at Dec. 31, 2019 $ 6,467 198,975,056 (192,823,958) 6,157,565
Ending balance, shares at Dec. 31, 2019 64,672,893      
Stock-based compensation expense 12,458,229 12,458,229
Issuance of common stock, net of issuance costs of $6,039,423 $ 3,375 136,361,526 136,364,901
Issuance of common stock, net of issuance costs, shares 33,752,192      
Issuance of common stock upon exercise of stock options $ 43 756,418 $ 756,461
Issuance of common stock upon exercise of stock options, shares 427,611     427,611
Fair value of warrants issued 807,149 $ 807,149
Net Loss     (111,269,380) (111,269,380)
Ending balance, value at Dec. 31, 2020 $ 9,885 $ 349,358,378 $ (304,093,338) $ 45,274,925
Ending balance, shares at Dec. 31, 2020 98,852,696